Femitraz Tablet contains Anastrozole 1mg, a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By blocking the enzyme aromatase, Anastrozole reduces estrogen production, which can slow or stop the growth of estrogen-dependent tumors. This medication is commonly prescribed as adjuvant therapy following surgery or radiation, as well as for advanced or metastatic breast cancer. Femitraz is typically taken once daily, with or without food, and dosage should be strictly followed as per the healthcare provider’s instructions. Common side effects may include hot flashes, joint pain, weakness, nausea, and headache, although not everyone experiences these. It is important to inform your doctor of any history of osteoporosis or cardiovascular disease before starting treatment, as Anastrozole can affect bone density and lipid profiles. Regular monitoring through blood tests and bone density scans may be recommended during therapy. Femitraz is not suitable for use in premenopausal women or during pregnancy. Patients should avoid abrupt discontinuation and consult their healthcare provider if they experience severe side effects or symptoms such as chest pain, severe bone pain, or unusual bleeding. Always store the medication in a cool, dry place away from direct sunlight.